HCW Biologics Inc.
HCWB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828673
In the last 90 days, HCW Biologics Inc. insiders filed 3 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $515.7K in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in HCW Biologics Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +2 vs. Q3 2024
- Shares held
- 3.13M
- +1.97M (+169.9%) vs. Q3 2024
- Total value
- $1.40M
- +$770.2K (+123.1%) vs. Q3 2024
- New holders
- 4
- 0 more added
- Sold out
- 2
- 6 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HCWB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $515.7K |
| Q1 2026 | 15 | $160.8K |
| Q4 2025 | 14 | $424.1K |
| Q3 2025 | 10 | $456.9K |
| Q2 2025 | 8 | $85.5K |
| Q1 2025 | 15 | $326.0K |
| Q4 2024 | 18 | $1.40M |
| Q3 2024 | 16 | $625.6K |
| Q2 2024 | 19 | $784.3K |
| Q1 2024 | 20 | $1.90M |
| Q4 2023 | 19 | $1.30M |
| Q3 2023 | 14 | $1.93M |
| Q2 2023 | 13 | $2.17M |
| Q1 2023 | 13 | $1.22M |
| Q4 2022 | 14 | $1.50M |
| Q3 2022 | 13 | $1.50M |
| Q2 2022 | 13 | $1.25M |
| Q1 2022 | 13 | $1.48M |
| Q4 2021 | 13 | $855.0K |
| Q3 2021 | 9 | $512.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding HCW Biologics Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 2,023,664 | $902.8K | 0.02% | +2,023,664 | New |
| Avantax Planning Partners, Inc. | 279,541 | $124.7K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 181,957 | $81.2K | 0.00% | −1,302−0.7% | Reduced |
| HighTower Advisors, LLC | 180,810 | $80.7K | 0.00% | 00.0% | Unchanged |
| Cresset Asset Management, LLC | 131,990 | $58.9K | 0.00% | 00.0% | Unchanged |
| Pullen Investment Management, LLC | 75,116 | $33.5K | 0.02% | 00.0% | Unchanged |
| BlackRock, Inc. | 42,989 | $19.2K | 0.00% | −1,359−3.1% | Reduced |
| Vanguard Group Inc | 37,677 | $16.8K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 34,700 | $15.5K | 0.00% | −50,000−59.0% | Reduced |
| XTX Topco Ltd | 33,999 | $15.2K | 0.00% | +33,999 | New |
| AE Wealth Management LLC | 30,000 | $13.4K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 21,446 | $9.57K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 15,623 | $7.00K | 0.00% | +15,623 | New |
| Renaissance Technologies LLC | 15,000 | $6.69K | 0.00% | +15,000 | New |
| Two Sigma Investments, LP | 12,082 | $5.39K | 0.00% | −10,361−46.2% | Reduced |
| Northern Trust Corp | 10,205 | $4.55K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,787 | $797 | 0.00% | −4,094−69.6% | Reduced |
| Bank of America Corp | 146 | $65 | 0.00% | −193−56.9% | Reduced |
| HRT Financial LP | 0 | $0 | 0.00% | −46,497−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −4,831−100.0% | Sold out |